Latest / Stock Movers / Rheinmetall Up, Lufthansa Climbs, Zealand Pharma Plunges
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, Podcasts, radio News.
- 0:08Speaker 2: The Stock Movers Report, your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 3: Let's look at some of the stocks on the move
- 0:18Speaker 3: today here in Europe. I'm Caroline Hepgar with Charles Caple,
- 0:21Speaker 3: and we're joined by Bloomberg reporter Chloe A.
- 0:22Speaker 1: Lay.
- 0:23Speaker 3: Good morning, Chloe, good morning. Let's start by thinking about
- 0:26Speaker 3: defense stocks. Ryan Mattau, how is it being affected by
- 0:30Speaker 3: the ongoing conflict in the Middle East and what might
- 0:33Speaker 3: happen in Europe.
- 0:34Speaker 1: Yeah, well, we have those defense names that have been
- 0:36Speaker 1: really on a positive trajectory throughout the week. Really so
- 0:40Speaker 1: we've seen Ryan Mattaw but also hensold Rank, all of
- 0:43Speaker 1: those names are really moving high end. This is a
- 0:45Speaker 1: continuation of that happening today because of course, more geopolitical tensions,
- 0:50Speaker 1: more conflicts, that's always kind of good news for those
- 0:52Speaker 1: defense companies. It means more military spending, or at least
- 0:56Speaker 1: the expectation of more military spending, and that then translates
- 0:59Speaker 1: into more orders, higher earnings. And so today we are
- 1:03Speaker 1: very much seeing that again with those names in the
- 1:05Speaker 1: green as well. And you know, the war is showing
- 1:08Speaker 1: no signs of letting up. We've got a Trumpers saying
- 1:11Speaker 1: that he wanted to clean out Around's leadership structure. He
- 1:14Speaker 1: had names in mind for a takeover. We've now got
- 1:17Speaker 1: a dozen countries are being embroiled in the conflict. So
- 1:21Speaker 1: until we've got more clarity on how this what ends
- 1:23Speaker 1: and when it ends, we're likely to see those defense
- 1:26Speaker 1: companies extend those gains further.
- 1:29Speaker 3: And now turning to lift Thansa, in what has been
- 1:32Speaker 3: a difficult time for airlines, talk us through their situation.
- 1:35Speaker 2: Yeah, it's very.
- 1:36Speaker 1: Interesting firm of Tansa, because you know the context of
- 1:39Speaker 1: the last few days have been really tough on airline
- 1:41Speaker 1: share prices and we've seen them really struggle because of
- 1:44Speaker 1: flight cancelations and then also the expectation of higher fuel prices.
- 1:49Speaker 1: But then today Liftansa came out with earnings and it
- 1:52Speaker 1: said that it expects profit in twenty twenty six to
- 1:55Speaker 1: be significantly above twenty twenty five, and then in terms
- 1:58Speaker 1: of its positioning with with the Middle East situation instead
- 2:02Speaker 1: of causes uncertainty that that is going to be a challenge,
- 2:05Speaker 1: But it also spoke about it as an opportunity. You know,
- 2:07Speaker 1: it was considering adding flights on routes to Asia and
- 2:11Speaker 1: Africa because of growing demand for long haul routes. So
- 2:14Speaker 1: this points to the conflict potentially being an opportunity for
- 2:18Speaker 1: airlines that are not based in the Middle East because
- 2:21Speaker 1: they can expand their capacity to connect Asia, Africa, Europe
- 2:25Speaker 1: without going through those Middle Eastern hubs. And so we
- 2:28Speaker 1: saw Luftanza shares moving higher but then also driving up
- 2:32Speaker 1: IAG and Ryanair this morning, so injecting a little bit
- 2:35Speaker 1: of optimism in that airline industry.
- 2:38Speaker 3: And then away from the fallout from the Middle East,
- 2:42Speaker 3: there is one company that has moved very significantly to
- 2:45Speaker 3: the downside. That is Zealand Farmer. What's the issue there.
- 2:48Speaker 1: Yeah, major major drop because of an experimental obesity drug
- 2:52Speaker 1: that it develops with Rush, which has really disappointed failed
- 2:55Speaker 1: to impress investors. So the shot help patient lose as
- 2:58Speaker 1: much as ten point seven but then that doesn't clear
- 3:01Speaker 1: the bar of thirteen to fifteen that was set by
- 3:04Speaker 1: some analyst, and now that really puts into question those
- 3:07Speaker 1: two companies' ability to make an entrance into that really
- 3:10Speaker 1: competitive obest market, which is of course dominated by Elay
- 3:14Speaker 1: Lilly and over Nordisk. But you know, this is really
- 3:17Speaker 1: a bit of a setback. The drug was really the
- 3:19Speaker 1: centerpiece of a big five billion dollar partnership between those
- 3:23Speaker 1: two companies. Not everything is over and everything is lost.
- 3:27Speaker 1: The side effects were pretty mild, and then the product
- 3:30Speaker 1: could be potentially positioned as a weight loss maintenance rather
- 3:33Speaker 1: than an initial weight loss. But in any case, the
- 3:37Speaker 1: sales expectations are definitely lower, and so that is really
- 3:40Speaker 1: dragging down those shares.
- 3:41Speaker 2: This morning the Stock Movers Report from Bloomberg Radio. Check
- 3:46Speaker 2: back with us throughout the day for the latest roundup
- 3:49Speaker 2: of companies making news on Wall Street and for the
- 3:52Speaker 2: latest market moving headlines. Listen to Bloomberg Radio Live, catch
- 3:56Speaker 2: us on YouTube, Bloomberg dot com, and on applecarplas and
- 4:00Speaker 2: Android Auto with the Bloomberg Business app MHM